Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
dsm-firmenich
dsm-firmenich
Activities:
Ingredients
Research & Development
Cardiovascular
Dietary supplements
Active Nutrition
Food
X
LinkedIn
Trending Articles
Symrise introduces health active solutions and concepts at Vitafoods Europe
The company will exhibit at booth D106, showcasing novel health active solutions that support gut health and immunity, healthy ageing and metabolic health
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
Activ’Inside exhibit premium formulas and ready-for-market nutraceutical solutions at Vitafoods
The company will present premium ingredient solutions that promote joint and skin health
Market-first synbiotic combination to launch at Vitafoods Europe 2024
Clasado Biosciences has revealed that Vitafoods Europe 2024 will see the European debut of its market-first synbiotic offering, developed in partnership with Probi AB
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
dsm-firmenich unveils Humiome B2 – the first ‘biotic’ vitamin – at Vitafoods
The targeted vitamin B2 delivery system is double layered to prevent premature absorption in the small intestine, and will be debuted at Vitafoods Europe 2024
Ingredients
dsm-firmenich and Lallemand partner to launch early life synbiotic solutions
The solution will contain a combination of human milk oligosaccharides (HMOs) that will mimic breast milk, boosting the infant immune system and gut microbiome
Finance
dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
The company has repurchased 500,000 shares for a total consideration of €51.6m
Ingredients
dsm-firmenich announces repurchase of 1.5m shares to cover share plans
The repurchasing of shares equates to around €156m
Cognitive
dsm-firmenich and OMG Pharma collaborate to advance CBD drugs for insomnia
Orally dispersible CBD tablets will improve consumer experience and ease of administration
Ingredients
dsm-firmenich announces its lineup for Vitafoods Europe 2024
The company will debut its gut health, omega-3 and vitamin D supplements
Finance
dsm-firmenich completes the divestiture of its Jiangshan vitamin C plant in China
Financial details of the transaction were not disclosed
Subscribe now